Foreign Trial Expectations Detailed in FDA Q&A Guidance
Sponsors should have an easier time submitting consistent, standardized data to show they are conducting non-IND foreign clinical studies under good clinical practices (GCP), thanks to a new FDA guidance on a 2008 rule change.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.